Clinical Trials List
Protocol Number104-4750A
2016-01-01 - 2017-06-30
Phase I
Study ended1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chi-Ting Liau Division of Hematology & Oncology
- Hung-Ming Wang Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
0 participants
